Hyperbaric ozone therapy: scientific considerations [abstract]

Auteurs-es

  • Robert Jay Rowen

DOI :

https://doi.org/10.7203/jo3t.3.4.2019.15534

Mots-clés :

hyperbaric ozone therapy

Résumé

BACKGROUND: This ozone world is little familiar with a modification of major autohemotherapy called hyperbaric ozone therapy (HBO3). This method may be a superior delivery system of ozone therapy, capturing benefits of intravenous oxygen gas as well as the oxidizing power of ozone therapy. MATERIAL and METHODS: I will discuss a scientific comparison between the largely reviled direct intravenous ozone administration and HBO3, inclusive of a safety/efficacy survey of practicing HBO3 physicians in America.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Références

Schmidt, H. [Regelsberger's intravenous oxygen therapy-an interpretation of results in practice from a biochemical and physiological point of view]. Forsch Komplementarmed Klass Naturheilkd. 2002;9(1):7-18.

Téléchargements

Publié-e

2019-12-19

Comment citer

Rowen, R. J. (2019). Hyperbaric ozone therapy: scientific considerations [abstract]. Journal of Ozone Therapy, 3(4), 54. https://doi.org/10.7203/jo3t.3.4.2019.15534
Metrics
Views/Downloads
  • Résumé
    541
  • PDF
    291

Numéro

Vol. 3 No. 4 (2019)

Rubrique

Proceedings

Licence

Journal of Ozone Therapy applies the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0) license to works we publish.

Creative Commons License

Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
You may not use the material for commercial purposes.

Appropriate attribution can be provided by simply citing the original article, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Metrics